Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease.
about
The molecular characterization of von Willebrand disease: good in partsPT-VWD posing diagnostic and therapeutic challenges - small case series.Analysis of the role of von Willebrand factor, platelet glycoprotein VI-, and α2β1-mediated collagen binding in thrombus formation.Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.Diagnostic approach to von Willebrand diseaseCrucial role for the VWF A1 domain in binding to type IV collagen.No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variationRapid discrimination of the phenotypic variants of von Willebrand disease.Variability in platelet- and collagen-binding defects in type 2M von Willebrand disease.Translational medicine advances in von Willebrand disease.von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.Perils, problems, and progress in laboratory diagnosis of von Willebrand disease.Making a diagnosis of VWD.Technological advances in diagnostic testing for von Willebrand disease: new approaches and challenges.VWF collagen (types III and VI)-binding defects in a cohort of type 2M VWD patients - a strategy for improvement of a challenging diagnosis.Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels.The Von Willebrand Factor A1-Collagen III Interaction Is Independent of Conformation and Type 2 Von Willebrand Disease Phenotype.The functions of the A1A2A3 domains in von Willebrand factor include multimerin 1 binding.
P2860
Q26996413-2FABF90A-46E2-447B-B1C4-33F179CA97C6Q33436573-FC850C11-8A01-421E-9EF1-19EB1FA0F55AQ34170382-742C7A60-ECF2-45A9-A30E-E50705EF6392Q34185963-F26CDA7F-E54C-4116-9C65-38CBB9BE5A7AQ34816051-15103654-8124-4194-A351-7C2F6BB16D27Q35220634-3D03EAC5-F2A1-45A6-9D2E-78D1AFC53E43Q35252688-A8457FF9-E457-4211-9B68-93C939EBF94EQ36814657-0C5BF02C-92ED-42EC-A43D-932850D0EDD7Q36920458-22C9EF98-0A42-4688-8FA1-1AB013E815EFQ36944971-DA789C80-00F1-4CFC-85AD-6F0423CD8224Q37602563-96096A79-BBDA-40ED-B3A3-68CF193AD2D0Q37635167-9C621E5B-6002-41E7-9E36-C40E2C1737AEQ37703427-045F0E74-3AA5-4055-986E-986024395C2FQ38066864-EFCCCCDF-40D4-40BA-BDD2-D07F1E1D77F3Q38205952-1C270422-341C-4F37-962D-BDC55A465F40Q45863626-D25E1D14-B16A-4B81-991F-D1E2D2CF6AB1Q47416217-62B4D0BB-E08E-40C8-9C44-E8BBEE6B586EQ49971473-FA8C7A62-8634-47A8-914E-EDF777C1DC9BQ55153557-9364D7BD-EECF-48A7-A77A-E255A9661081
P2860
Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of type I, type III ...... sis of von Willebrand disease.
@en
Comparison of type I, type III ...... sis of von Willebrand disease.
@nl
type
label
Comparison of type I, type III ...... sis of von Willebrand disease.
@en
Comparison of type I, type III ...... sis of von Willebrand disease.
@nl
prefLabel
Comparison of type I, type III ...... sis of von Willebrand disease.
@en
Comparison of type I, type III ...... sis of von Willebrand disease.
@nl
P2093
P2860
P1476
Comparison of type I, type III ...... sis of von Willebrand disease.
@en
P2093
K D Friedman
P A Christopherson
R G Hoffmann
R R Montgomery
S L Haberichter
P2860
P304
P356
10.1111/J.1538-7836.2012.04747.X
P577
2012-07-01T00:00:00Z